Nwam »

Corvus Pharmaceuticals shares owned by Nwam

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Nwam from 13F filings

Historical chart of Nwam investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Nwam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Nwam

Quarter filed Position value Share count Share price at filing
2024-12-31 $83k 16k 5.35
2024-09-30 $53k 10k 5.28

More positions owned by Nwam

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p Ttl Stk (ITOT)
Costco Wholesale Corporation (COST)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Nwam

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
BlackRock
Vanguard Group
Adams Street Partners
Rtw Investments
Vivo Capital
Foresite Capital Management VI
Geode Capital Management
Perceptive Advisors
State Street Corporation
Morgan Stanley
Northern Trust
Goldman Sachs Group
Sphera Funds Management

View all funds holding Corvus Pharmaceuticals